

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.63855712 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.45494084 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.39407611 |
| 4 | neuronal action potential propagation (GO:0019227) | 5.37178589 |
| 5 | locomotory exploration behavior (GO:0035641) | 5.33154851 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 5.32722888 |
| 7 | glutamate secretion (GO:0014047) | 5.07256080 |
| 8 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.03358697 |
| 9 | central nervous system myelination (GO:0022010) | 4.97633606 |
| 10 | axon ensheathment in central nervous system (GO:0032291) | 4.97633606 |
| 11 | vocalization behavior (GO:0071625) | 4.97108557 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.92241153 |
| 13 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.83925400 |
| 14 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.82734374 |
| 15 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.80006854 |
| 16 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.53609663 |
| 17 | regulation of synaptic vesicle transport (GO:1902803) | 4.40193132 |
| 18 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.37079879 |
| 19 | synaptic transmission, glutamatergic (GO:0035249) | 4.36390216 |
| 20 | neuron cell-cell adhesion (GO:0007158) | 4.32538372 |
| 21 | protein localization to synapse (GO:0035418) | 4.31618697 |
| 22 | glutamate receptor signaling pathway (GO:0007215) | 4.29367707 |
| 23 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.29052481 |
| 24 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.28421531 |
| 25 | neuron-neuron synaptic transmission (GO:0007270) | 4.25321974 |
| 26 | neurotransmitter secretion (GO:0007269) | 4.18218835 |
| 27 | exploration behavior (GO:0035640) | 4.07241137 |
| 28 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.02242505 |
| 29 | negative regulation of dendrite development (GO:2000171) | 3.99313988 |
| 30 | gamma-aminobutyric acid transport (GO:0015812) | 3.90299540 |
| 31 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.87840394 |
| 32 | C4-dicarboxylate transport (GO:0015740) | 3.86093021 |
| 33 | regulation of synapse structural plasticity (GO:0051823) | 3.85903381 |
| 34 | long-term memory (GO:0007616) | 3.85185868 |
| 35 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.84093420 |
| 36 | cellular potassium ion homeostasis (GO:0030007) | 3.82459552 |
| 37 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.79320871 |
| 38 | potassium ion homeostasis (GO:0055075) | 3.77459655 |
| 39 | potassium ion import (GO:0010107) | 3.76755625 |
| 40 | positive regulation of membrane potential (GO:0045838) | 3.71588407 |
| 41 | regulation of postsynaptic membrane potential (GO:0060078) | 3.65864035 |
| 42 | * regulation of synaptic plasticity (GO:0048167) | 3.64717977 |
| 43 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.62462669 |
| 44 | transmission of nerve impulse (GO:0019226) | 3.62199648 |
| 45 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.62116784 |
| 46 | cellular sodium ion homeostasis (GO:0006883) | 3.61662968 |
| 47 | dendritic spine morphogenesis (GO:0060997) | 3.56918060 |
| 48 | serotonin metabolic process (GO:0042428) | 3.55499307 |
| 49 | neuromuscular process controlling posture (GO:0050884) | 3.52811375 |
| 50 | neurotransmitter transport (GO:0006836) | 3.47859340 |
| 51 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.43679474 |
| 52 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.43534486 |
| 53 | * long-term synaptic potentiation (GO:0060291) | 3.40731441 |
| 54 | presynaptic membrane assembly (GO:0097105) | 3.39995488 |
| 55 | L-amino acid import (GO:0043092) | 3.39567634 |
| 56 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.37054026 |
| 57 | neuron recognition (GO:0008038) | 3.36711811 |
| 58 | regulation of neurotransmitter secretion (GO:0046928) | 3.34863343 |
| 59 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.33335686 |
| 60 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.33226026 |
| 61 | presynaptic membrane organization (GO:0097090) | 3.32171828 |
| 62 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.31418216 |
| 63 | sodium ion export (GO:0071436) | 3.31381240 |
| 64 | neuromuscular process controlling balance (GO:0050885) | 3.30520667 |
| 65 | amino acid import (GO:0043090) | 3.29145674 |
| 66 | membrane depolarization during action potential (GO:0086010) | 3.28671291 |
| 67 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.26843286 |
| 68 | layer formation in cerebral cortex (GO:0021819) | 3.26679841 |
| 69 | activation of protein kinase A activity (GO:0034199) | 3.25551831 |
| 70 | positive regulation of dendritic spine development (GO:0060999) | 3.24451066 |
| 71 | cell differentiation in hindbrain (GO:0021533) | 3.24325496 |
| 72 | synaptic vesicle endocytosis (GO:0048488) | 3.24120864 |
| 73 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.23916202 |
| 74 | membrane depolarization (GO:0051899) | 3.23902886 |
| 75 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.22102954 |
| 76 | proline transport (GO:0015824) | 3.21959594 |
| 77 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.21913999 |
| 78 | regulation of neurotransmitter levels (GO:0001505) | 3.20264801 |
| 79 | regulation of synapse maturation (GO:0090128) | 3.19997265 |
| 80 | acidic amino acid transport (GO:0015800) | 3.19969227 |
| 81 | primary amino compound metabolic process (GO:1901160) | 3.19622105 |
| 82 | neuronal ion channel clustering (GO:0045161) | 3.19134882 |
| 83 | detection of calcium ion (GO:0005513) | 3.18521945 |
| 84 | adult walking behavior (GO:0007628) | 3.17419130 |
| 85 | regulation of neurotransmitter transport (GO:0051588) | 3.16226352 |
| 86 | neurotransmitter uptake (GO:0001504) | 3.14506235 |
| 87 | positive regulation of synapse maturation (GO:0090129) | 3.13308291 |
| 88 | membrane hyperpolarization (GO:0060081) | 3.11756685 |
| 89 | regulation of vesicle fusion (GO:0031338) | 3.11650742 |
| 90 | axonal fasciculation (GO:0007413) | 3.11377069 |
| 91 | positive regulation of neurotransmitter transport (GO:0051590) | 3.10775699 |
| 92 | response to histamine (GO:0034776) | 3.09842812 |
| 93 | innervation (GO:0060384) | 3.06973894 |
| 94 | glycine transport (GO:0015816) | 3.05798917 |
| 95 | vesicle transport along microtubule (GO:0047496) | 3.04958224 |
| 96 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.04881454 |
| 97 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.04549189 |
| 98 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.04084544 |
| 99 | behavioral response to cocaine (GO:0048148) | 3.04058914 |
| 100 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.04034381 |
| 101 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.02378184 |
| 102 | auditory behavior (GO:0031223) | 3.01843894 |
| 103 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.01838460 |
| 104 | synaptic transmission (GO:0007268) | 3.01418011 |
| 105 | neuromuscular process (GO:0050905) | 3.01268675 |
| 106 | cerebellar granule cell differentiation (GO:0021707) | 3.00872828 |
| 107 | behavioral defense response (GO:0002209) | 3.00739895 |
| 108 | behavioral fear response (GO:0001662) | 3.00739895 |
| 109 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.00568202 |
| 110 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.00207514 |
| 111 | * regulation of synaptic transmission (GO:0050804) | 2.98983150 |
| 112 | chemosensory behavior (GO:0007635) | 2.97599027 |
| 113 | * learning (GO:0007612) | 2.97146967 |
| 114 | glycosphingolipid biosynthetic process (GO:0006688) | 2.96992379 |
| 115 | multicellular organismal signaling (GO:0035637) | 2.95460962 |
| 116 | cell communication by electrical coupling (GO:0010644) | 2.94751566 |
| 117 | regulation of dendritic spine development (GO:0060998) | 2.93756695 |
| 118 | startle response (GO:0001964) | 2.92739929 |
| 119 | cellular potassium ion transport (GO:0071804) | 2.92406569 |
| 120 | potassium ion transmembrane transport (GO:0071805) | 2.92406569 |
| 121 | response to auditory stimulus (GO:0010996) | 2.90973727 |
| 122 | striatum development (GO:0021756) | 2.90737331 |
| 123 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.90604386 |
| 124 | postsynaptic membrane organization (GO:0001941) | 2.90016096 |
| 125 | L-glutamate transport (GO:0015813) | 2.89394461 |
| 126 | prepulse inhibition (GO:0060134) | 2.88679800 |
| 127 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.86550076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.97232406 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.89607880 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.11076018 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.04780775 |
| 5 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.97582277 |
| 6 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.68516392 |
| 7 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.64170187 |
| 8 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.61759413 |
| 9 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.61759413 |
| 10 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.57034569 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.54560888 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.51679135 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.49801672 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.48401890 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.43248150 |
| 16 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.37066364 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.34276848 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.16898795 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.16187675 |
| 20 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.15025389 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.10816943 |
| 22 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.10303799 |
| 23 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.00959735 |
| 24 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.98469094 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.87928375 |
| 26 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.82919131 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.81393278 |
| 28 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.80592362 |
| 29 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.75236588 |
| 30 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.72702725 |
| 31 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.72165299 |
| 32 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.63742627 |
| 33 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.62630653 |
| 34 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.61882514 |
| 35 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.55103250 |
| 36 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.52420250 |
| 37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.47020447 |
| 38 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.43764465 |
| 39 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.42099327 |
| 40 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.40762377 |
| 41 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.38306009 |
| 42 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.38153881 |
| 43 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.36834101 |
| 44 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.36357567 |
| 45 | STAT3_23295773_ChIP-Seq_U87_Human | 1.34997364 |
| 46 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34605923 |
| 47 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33502095 |
| 48 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.31939862 |
| 49 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29221780 |
| 50 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.28391246 |
| 51 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.27617807 |
| 52 | AR_25329375_ChIP-Seq_VCAP_Human | 1.26422369 |
| 53 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.24177384 |
| 54 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.22926139 |
| 55 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.21870466 |
| 56 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.20315963 |
| 57 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.18958602 |
| 58 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18301212 |
| 59 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.18030346 |
| 60 | AR_19668381_ChIP-Seq_PC3_Human | 1.17609505 |
| 61 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.17137861 |
| 62 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.16844398 |
| 63 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.16769155 |
| 64 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.16683889 |
| 65 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.16023848 |
| 66 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.15902516 |
| 67 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.15296415 |
| 68 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15296415 |
| 69 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.14915999 |
| 70 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14566158 |
| 71 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.13043454 |
| 72 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.11768473 |
| 73 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.11610353 |
| 74 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.11066266 |
| 75 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.09966382 |
| 76 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.09952557 |
| 77 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.09927466 |
| 78 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.07518201 |
| 79 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.06671142 |
| 80 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.06366672 |
| 81 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06276435 |
| 82 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.06195983 |
| 83 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.05650147 |
| 84 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.05284872 |
| 85 | EWS_26573619_Chip-Seq_HEK293_Human | 1.04905490 |
| 86 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.04421752 |
| 87 | KDM2B_26808549_Chip-Seq_REH_Human | 1.04012206 |
| 88 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.03054729 |
| 89 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01645363 |
| 90 | JUN_21703547_ChIP-Seq_K562_Human | 1.01563961 |
| 91 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.01312568 |
| 92 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.01230423 |
| 93 | FUS_26573619_Chip-Seq_HEK293_Human | 1.01138252 |
| 94 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.01024594 |
| 95 | TP53_16413492_ChIP-PET_HCT116_Human | 1.00929098 |
| 96 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.00387134 |
| 97 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.00387134 |
| 98 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.99935371 |
| 99 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.99418417 |
| 100 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99179110 |
| 101 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.98640281 |
| 102 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98560857 |
| 103 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.97116450 |
| 104 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.96671295 |
| 105 | VDR_22108803_ChIP-Seq_LS180_Human | 0.96316963 |
| 106 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93449113 |
| 107 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93366611 |
| 108 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.92845393 |
| 109 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.92623988 |
| 110 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.92604404 |
| 111 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.92439562 |
| 112 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.91276922 |
| 113 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90626661 |
| 114 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.90054231 |
| 115 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.89674853 |
| 116 | RXR_22108803_ChIP-Seq_LS180_Human | 0.89151296 |
| 117 | KDM2B_26808549_Chip-Seq_K562_Human | 0.87021634 |
| 118 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.85251342 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.57419461 |
| 2 | MP0003880_abnormal_central_pattern | 5.11731804 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 4.14196342 |
| 4 | MP0004270_analgesia | 4.04307391 |
| 5 | MP0009745_abnormal_behavioral_response | 3.49696538 |
| 6 | MP0009046_muscle_twitch | 3.37611965 |
| 7 | MP0002064_seizures | 3.36839809 |
| 8 | * MP0002063_abnormal_learning/memory/cond | 3.26529564 |
| 9 | MP0001968_abnormal_touch/_nociception | 2.95344489 |
| 10 | MP0002272_abnormal_nervous_system | 2.94918431 |
| 11 | MP0002822_catalepsy | 2.94831076 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.82468105 |
| 13 | MP0001486_abnormal_startle_reflex | 2.75386713 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.63880605 |
| 15 | MP0005423_abnormal_somatic_nervous | 2.41084861 |
| 16 | MP0002736_abnormal_nociception_after | 2.34741234 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.34316202 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.18098532 |
| 19 | MP0008569_lethality_at_weaning | 2.05669897 |
| 20 | MP0002067_abnormal_sensory_capabilities | 2.05203719 |
| 21 | MP0001440_abnormal_grooming_behavior | 2.02112551 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 1.96304333 |
| 23 | MP0001970_abnormal_pain_threshold | 1.95625819 |
| 24 | MP0002733_abnormal_thermal_nociception | 1.93274841 |
| 25 | MP0003329_amyloid_beta_deposits | 1.89163955 |
| 26 | MP0005646_abnormal_pituitary_gland | 1.84206873 |
| 27 | MP0005386_behavior/neurological_phenoty | 1.72082339 |
| 28 | MP0004924_abnormal_behavior | 1.72082339 |
| 29 | MP0002909_abnormal_adrenal_gland | 1.67703002 |
| 30 | MP0004811_abnormal_neuron_physiology | 1.65842260 |
| 31 | MP0002184_abnormal_innervation | 1.64538442 |
| 32 | MP0008877_abnormal_DNA_methylation | 1.63338921 |
| 33 | MP0003879_abnormal_hair_cell | 1.61619025 |
| 34 | MP0002557_abnormal_social/conspecific_i | 1.60235880 |
| 35 | MP0000778_abnormal_nervous_system | 1.60000495 |
| 36 | MP0001984_abnormal_olfaction | 1.53377993 |
| 37 | MP0000955_abnormal_spinal_cord | 1.53088042 |
| 38 | MP0003633_abnormal_nervous_system | 1.51529742 |
| 39 | MP0001529_abnormal_vocalization | 1.50440752 |
| 40 | MP0004885_abnormal_endolymph | 1.47462403 |
| 41 | MP0002066_abnormal_motor_capabilities/c | 1.46570147 |
| 42 | MP0004858_abnormal_nervous_system | 1.45774613 |
| 43 | MP0002882_abnormal_neuron_morphology | 1.40979024 |
| 44 | MP0004142_abnormal_muscle_tone | 1.40695033 |
| 45 | MP0000920_abnormal_myelination | 1.38088847 |
| 46 | MP0003787_abnormal_imprinting | 1.37657036 |
| 47 | MP0004147_increased_porphyrin_level | 1.34863736 |
| 48 | MP0001905_abnormal_dopamine_level | 1.32499231 |
| 49 | MP0006276_abnormal_autonomic_nervous | 1.29907610 |
| 50 | MP0003631_nervous_system_phenotype | 1.27948534 |
| 51 | MP0005645_abnormal_hypothalamus_physiol | 1.16818604 |
| 52 | MP0002229_neurodegeneration | 1.16489072 |
| 53 | MP0003690_abnormal_glial_cell | 1.15196533 |
| 54 | MP0001502_abnormal_circadian_rhythm | 1.14258966 |
| 55 | MP0004145_abnormal_muscle_electrophysio | 1.10562778 |
| 56 | MP0004742_abnormal_vestibular_system | 1.07409378 |
| 57 | MP0002638_abnormal_pupillary_reflex | 1.04619125 |
| 58 | MP0001188_hyperpigmentation | 1.02335749 |
| 59 | MP0002152_abnormal_brain_morphology | 1.02121275 |
| 60 | MP0004043_abnormal_pH_regulation | 1.00467333 |
| 61 | MP0001485_abnormal_pinna_reflex | 1.00466721 |
| 62 | MP0000013_abnormal_adipose_tissue | 0.98763980 |
| 63 | MP0008872_abnormal_physiological_respon | 0.98682237 |
| 64 | MP0003634_abnormal_glial_cell | 0.97197494 |
| 65 | MP0005551_abnormal_eye_electrophysiolog | 0.96937475 |
| 66 | MP0008874_decreased_physiological_sensi | 0.96434532 |
| 67 | MP0003122_maternal_imprinting | 0.95172011 |
| 68 | MP0003632_abnormal_nervous_system | 0.92301956 |
| 69 | MP0001177_atelectasis | 0.91655896 |
| 70 | MP0001963_abnormal_hearing_physiology | 0.91487166 |
| 71 | MP0001986_abnormal_taste_sensitivity | 0.91438207 |
| 72 | MP0000751_myopathy | 0.90682031 |
| 73 | MP0002069_abnormal_eating/drinking_beha | 0.89879730 |
| 74 | MP0010386_abnormal_urinary_bladder | 0.89361531 |
| 75 | MP0005409_darkened_coat_color | 0.86763460 |
| 76 | MP0003075_altered_response_to | 0.86207434 |
| 77 | MP0004085_abnormal_heartbeat | 0.84361199 |
| 78 | MP0000604_amyloidosis | 0.84253640 |
| 79 | MP0006072_abnormal_retinal_apoptosis | 0.82027093 |
| 80 | MP0005535_abnormal_body_temperature | 0.80724712 |
| 81 | MP0003283_abnormal_digestive_organ | 0.78750668 |
| 82 | MP0005253_abnormal_eye_physiology | 0.77344081 |
| 83 | MP0008875_abnormal_xenobiotic_pharmacok | 0.74969982 |
| 84 | MP0002837_dystrophic_cardiac_calcinosis | 0.73866181 |
| 85 | MP0002752_abnormal_somatic_nervous | 0.73015563 |
| 86 | MP0004215_abnormal_myocardial_fiber | 0.71068873 |
| 87 | MP0003121_genomic_imprinting | 0.68616581 |
| 88 | MP0005499_abnormal_olfactory_system | 0.68182994 |
| 89 | MP0005394_taste/olfaction_phenotype | 0.68182994 |
| 90 | MP0004484_altered_response_of | 0.67384144 |
| 91 | MP0002876_abnormal_thyroid_physiology | 0.65527342 |
| 92 | MP0004130_abnormal_muscle_cell | 0.65429697 |
| 93 | MP0001664_abnormal_digestion | 0.64678831 |
| 94 | MP0000631_abnormal_neuroendocrine_gland | 0.64440138 |
| 95 | MP0005171_absent_coat_pigmentation | 0.63735192 |
| 96 | MP0002090_abnormal_vision | 0.63254138 |
| 97 | MP0003137_abnormal_impulse_conducting | 0.60742832 |
| 98 | MP0001299_abnormal_eye_distance/ | 0.60331167 |
| 99 | MP0003123_paternal_imprinting | 0.59770682 |
| 100 | MP0004510_myositis | 0.58095849 |
| 101 | MP0005187_abnormal_penis_morphology | 0.56171507 |
| 102 | MP0000026_abnormal_inner_ear | 0.55708858 |
| 103 | MP0002160_abnormal_reproductive_system | 0.55373162 |
| 104 | MP0003183_abnormal_peptide_metabolism | 0.55128981 |
| 105 | MP0000569_abnormal_digit_pigmentation | 0.54617153 |
| 106 | MP0005623_abnormal_meninges_morphology | 0.54533263 |
| 107 | MP0002082_postnatal_lethality | 0.54287392 |
| 108 | MP0010770_preweaning_lethality | 0.54287392 |
| 109 | MP0005167_abnormal_blood-brain_barrier | 0.53592459 |
| 110 | MP0001943_abnormal_respiration | 0.53497234 |
| 111 | MP0010768_mortality/aging | 0.52697694 |
| 112 | MP0010769_abnormal_survival | 0.50810718 |
| 113 | MP0006292_abnormal_olfactory_placode | 0.50285977 |
| 114 | MP0004233_abnormal_muscle_weight | 0.49811016 |
| 115 | MP0005410_abnormal_fertilization | 0.49536201 |
| 116 | MP0008961_abnormal_basal_metabolism | 0.49492508 |
| 117 | MP0003956_abnormal_body_size | 0.48930208 |
| 118 | MP0001348_abnormal_lacrimal_gland | 0.47996277 |
| 119 | MP0002751_abnormal_autonomic_nervous | 0.47984664 |
| 120 | MP0002234_abnormal_pharynx_morphology | 0.46844292 |
| 121 | MP0002102_abnormal_ear_morphology | 0.46617059 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.59723923 |
| 2 | Myokymia (HP:0002411) | 7.24306006 |
| 3 | Focal seizures (HP:0007359) | 5.95899581 |
| 4 | Atonic seizures (HP:0010819) | 5.38460826 |
| 5 | Epileptic encephalopathy (HP:0200134) | 5.07453106 |
| 6 | Febrile seizures (HP:0002373) | 4.91832932 |
| 7 | Visual hallucinations (HP:0002367) | 4.65010407 |
| 8 | Absence seizures (HP:0002121) | 4.53263098 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 4.39781471 |
| 10 | Action tremor (HP:0002345) | 4.34859064 |
| 11 | Dialeptic seizures (HP:0011146) | 4.20174943 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 4.06374715 |
| 13 | Gaze-evoked nystagmus (HP:0000640) | 3.82701874 |
| 14 | Dysmetria (HP:0001310) | 3.64670957 |
| 15 | Supranuclear gaze palsy (HP:0000605) | 3.64226574 |
| 16 | Broad-based gait (HP:0002136) | 3.57112484 |
| 17 | Hyperventilation (HP:0002883) | 3.55854655 |
| 18 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.51483352 |
| 19 | Dysdiadochokinesis (HP:0002075) | 3.47071504 |
| 20 | Ankle clonus (HP:0011448) | 3.46321069 |
| 21 | Scanning speech (HP:0002168) | 3.34976828 |
| 22 | Truncal ataxia (HP:0002078) | 3.30620112 |
| 23 | Poor eye contact (HP:0000817) | 3.24586413 |
| 24 | Depression (HP:0000716) | 3.15038324 |
| 25 | Anxiety (HP:0000739) | 3.04680592 |
| 26 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.04391338 |
| 27 | Impaired social interactions (HP:0000735) | 2.98176271 |
| 28 | Abnormal social behavior (HP:0012433) | 2.98176271 |
| 29 | Spastic gait (HP:0002064) | 2.92035558 |
| 30 | Amblyopia (HP:0000646) | 2.88092912 |
| 31 | Postural instability (HP:0002172) | 2.87654715 |
| 32 | Intention tremor (HP:0002080) | 2.85784213 |
| 33 | Neurofibrillary tangles (HP:0002185) | 2.84307842 |
| 34 | Abnormal eating behavior (HP:0100738) | 2.79802915 |
| 35 | Impaired smooth pursuit (HP:0007772) | 2.79663079 |
| 36 | Pheochromocytoma (HP:0002666) | 2.78743006 |
| 37 | Urinary urgency (HP:0000012) | 2.75369149 |
| 38 | Termporal pattern (HP:0011008) | 2.70800842 |
| 39 | Insidious onset (HP:0003587) | 2.70800842 |
| 40 | Epileptiform EEG discharges (HP:0011182) | 2.62796357 |
| 41 | Cerebral inclusion bodies (HP:0100314) | 2.57203019 |
| 42 | Hemiparesis (HP:0001269) | 2.56947014 |
| 43 | Abnormality of the corticospinal tract (HP:0002492) | 2.55245583 |
| 44 | Cerebral hypomyelination (HP:0006808) | 2.52115310 |
| 45 | Impaired vibratory sensation (HP:0002495) | 2.49441074 |
| 46 | Progressive inability to walk (HP:0002505) | 2.49279094 |
| 47 | Dysmetric saccades (HP:0000641) | 2.48801987 |
| 48 | Torticollis (HP:0000473) | 2.47576474 |
| 49 | Genetic anticipation (HP:0003743) | 2.47561499 |
| 50 | Diplopia (HP:0000651) | 2.46002503 |
| 51 | Abnormality of binocular vision (HP:0011514) | 2.46002503 |
| 52 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.45132939 |
| 53 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.45132939 |
| 54 | Drooling (HP:0002307) | 2.45028869 |
| 55 | Excessive salivation (HP:0003781) | 2.45028869 |
| 56 | Neuroendocrine neoplasm (HP:0100634) | 2.41678372 |
| 57 | Bradykinesia (HP:0002067) | 2.41080923 |
| 58 | EEG with generalized epileptiform discharges (HP:0011198) | 2.40098857 |
| 59 | Focal dystonia (HP:0004373) | 2.39355709 |
| 60 | Hemiplegia (HP:0002301) | 2.37604585 |
| 61 | Papilledema (HP:0001085) | 2.37410703 |
| 62 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.36178191 |
| 63 | Absent speech (HP:0001344) | 2.34355534 |
| 64 | Stereotypic behavior (HP:0000733) | 2.29340589 |
| 65 | Generalized myoclonic seizures (HP:0002123) | 2.27087278 |
| 66 | Hypsarrhythmia (HP:0002521) | 2.25221046 |
| 67 | Status epilepticus (HP:0002133) | 2.25184484 |
| 68 | Lower limb muscle weakness (HP:0007340) | 2.23618367 |
| 69 | Mutism (HP:0002300) | 2.22789957 |
| 70 | Megalencephaly (HP:0001355) | 2.21973559 |
| 71 | Abnormality of the lower motor neuron (HP:0002366) | 2.18707943 |
| 72 | Fetal akinesia sequence (HP:0001989) | 2.18529342 |
| 73 | Ventricular fibrillation (HP:0001663) | 2.15999430 |
| 74 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.13312858 |
| 75 | Annular pancreas (HP:0001734) | 2.11068996 |
| 76 | Abnormality of saccadic eye movements (HP:0000570) | 2.09855841 |
| 77 | Craniofacial dystonia (HP:0012179) | 2.09356929 |
| 78 | Gait ataxia (HP:0002066) | 2.07521438 |
| 79 | Syncope (HP:0001279) | 2.07233356 |
| 80 | Resting tremor (HP:0002322) | 2.06524460 |
| 81 | Blue irides (HP:0000635) | 2.06000171 |
| 82 | Clonus (HP:0002169) | 2.01510987 |
| 83 | Inability to walk (HP:0002540) | 2.00944685 |
| 84 | Neuronal loss in central nervous system (HP:0002529) | 1.98301149 |
| 85 | Peripheral hypomyelination (HP:0007182) | 1.97644354 |
| 86 | Incomplete penetrance (HP:0003829) | 1.96708953 |
| 87 | Prolonged QT interval (HP:0001657) | 1.89589573 |
| 88 | Thickened helices (HP:0000391) | 1.86382085 |
| 89 | Psychosis (HP:0000709) | 1.84435752 |
| 90 | Rigidity (HP:0002063) | 1.82644579 |
| 91 | Akinesia (HP:0002304) | 1.80992551 |
| 92 | Polyphagia (HP:0002591) | 1.80761131 |
| 93 | Spastic tetraparesis (HP:0001285) | 1.79937768 |
| 94 | Amyotrophic lateral sclerosis (HP:0007354) | 1.79041345 |
| 95 | Stomach cancer (HP:0012126) | 1.78334514 |
| 96 | Onion bulb formation (HP:0003383) | 1.77059408 |
| 97 | Delusions (HP:0000746) | 1.76352306 |
| 98 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.75658306 |
| 99 | Increased circulating renin level (HP:0000848) | 1.75139493 |
| 100 | Postural tremor (HP:0002174) | 1.75068257 |
| 101 | Abnormality of salivation (HP:0100755) | 1.74843883 |
| 102 | Specific learning disability (HP:0001328) | 1.74623800 |
| 103 | Bundle branch block (HP:0011710) | 1.73918258 |
| 104 | Clumsiness (HP:0002312) | 1.73423156 |
| 105 | Limb dystonia (HP:0002451) | 1.73182836 |
| 106 | Retinal dysplasia (HP:0007973) | 1.72853384 |
| 107 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.72234948 |
| 108 | Abnormal EKG (HP:0003115) | 1.71816731 |
| 109 | Sleep apnea (HP:0010535) | 1.71494861 |
| 110 | Congenital stationary night blindness (HP:0007642) | 1.71022253 |
| 111 | Hamartoma of the eye (HP:0010568) | 1.70887832 |
| 112 | Gait imbalance (HP:0002141) | 1.68239421 |
| 113 | Protruding tongue (HP:0010808) | 1.67503478 |
| 114 | Horizontal nystagmus (HP:0000666) | 1.65398112 |
| 115 | Spastic tetraplegia (HP:0002510) | 1.64273775 |
| 116 | CNS hypomyelination (HP:0003429) | 1.63763519 |
| 117 | Abolished electroretinogram (ERG) (HP:0000550) | 1.62462873 |
| 118 | Tetraplegia (HP:0002445) | 1.62061787 |
| 119 | Nephronophthisis (HP:0000090) | 1.57254262 |
| 120 | Inappropriate behavior (HP:0000719) | 1.57246691 |
| 121 | Metabolic alkalosis (HP:0200114) | 1.55632350 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.74566772 |
| 2 | NTRK3 | 4.60647611 |
| 3 | MAP3K9 | 3.30859848 |
| 4 | FRK | 2.95245693 |
| 5 | MAP3K4 | 2.91289943 |
| 6 | RIPK4 | 2.53258568 |
| 7 | MINK1 | 2.49974389 |
| 8 | MAP2K7 | 2.48928736 |
| 9 | DAPK2 | 2.37470900 |
| 10 | PAK6 | 2.15250991 |
| 11 | CASK | 2.12397920 |
| 12 | PRKD3 | 2.09837264 |
| 13 | KSR2 | 2.02228720 |
| 14 | CDK19 | 2.01333294 |
| 15 | NTRK1 | 2.00208854 |
| 16 | MAP3K12 | 1.91201332 |
| 17 | MAP2K4 | 1.83209700 |
| 18 | MARK1 | 1.81262771 |
| 19 | CAMKK1 | 1.77930560 |
| 20 | PRPF4B | 1.76941187 |
| 21 | NTRK2 | 1.71692781 |
| 22 | TNIK | 1.67382149 |
| 23 | OXSR1 | 1.66236009 |
| 24 | DAPK1 | 1.62491254 |
| 25 | CDK5 | 1.54889622 |
| 26 | ARAF | 1.40280580 |
| 27 | CAMKK2 | 1.36008544 |
| 28 | PNCK | 1.34492211 |
| 29 | KSR1 | 1.32531183 |
| 30 | PLK2 | 1.31478125 |
| 31 | MAP3K2 | 1.26434690 |
| 32 | SGK223 | 1.23834768 |
| 33 | SGK494 | 1.23834768 |
| 34 | CAMK2B | 1.23229274 |
| 35 | STK38 | 1.22751628 |
| 36 | PRKCG | 1.21557037 |
| 37 | STK39 | 1.19046372 |
| 38 | FES | 1.18579752 |
| 39 | UHMK1 | 1.18488492 |
| 40 | GRK5 | 1.18408198 |
| 41 | BMPR2 | 1.18267509 |
| 42 | MAP3K13 | 1.17465641 |
| 43 | CAMK2A | 1.11551480 |
| 44 | MAPK13 | 1.09806553 |
| 45 | WNK1 | 1.01552855 |
| 46 | PKN1 | 0.98626531 |
| 47 | TYRO3 | 0.94860905 |
| 48 | SGK2 | 0.91058522 |
| 49 | PTK2B | 0.90402612 |
| 50 | PINK1 | 0.89578277 |
| 51 | PRKCH | 0.87851270 |
| 52 | CAMK1 | 0.87733386 |
| 53 | CDK18 | 0.87349780 |
| 54 | CDK15 | 0.85222235 |
| 55 | CDK14 | 0.83811081 |
| 56 | PDK1 | 0.82921078 |
| 57 | PDPK1 | 0.82392396 |
| 58 | STK11 | 0.80946080 |
| 59 | GRK1 | 0.80835875 |
| 60 | SIK2 | 0.80025540 |
| 61 | CSNK1A1L | 0.79656589 |
| 62 | CSNK1G3 | 0.79552333 |
| 63 | ADRBK2 | 0.79497102 |
| 64 | MAP4K2 | 0.78520646 |
| 65 | NEK6 | 0.78094653 |
| 66 | SGK3 | 0.76327697 |
| 67 | CAMK2D | 0.75817573 |
| 68 | RAF1 | 0.75771524 |
| 69 | RET | 0.74857388 |
| 70 | AKT3 | 0.74582683 |
| 71 | SGK1 | 0.73777395 |
| 72 | CDK11A | 0.72938414 |
| 73 | PAK3 | 0.69922346 |
| 74 | MAP3K1 | 0.67793882 |
| 75 | PHKG1 | 0.65964266 |
| 76 | PHKG2 | 0.65964266 |
| 77 | CAMK2G | 0.65097662 |
| 78 | NME1 | 0.62620194 |
| 79 | CSNK1G1 | 0.61994182 |
| 80 | CSNK1D | 0.61863850 |
| 81 | MAPKAPK5 | 0.61394549 |
| 82 | PRKG1 | 0.61129740 |
| 83 | MARK2 | 0.60963171 |
| 84 | TNK2 | 0.60608678 |
| 85 | WNK4 | 0.59074820 |
| 86 | PRKCE | 0.58952609 |
| 87 | TAOK1 | 0.57669674 |
| 88 | LMTK2 | 0.57202659 |
| 89 | CSNK1G2 | 0.56418064 |
| 90 | PRKCA | 0.54277079 |
| 91 | DYRK1A | 0.51312306 |
| 92 | PRKACA | 0.50804318 |
| 93 | ROCK2 | 0.50425583 |
| 94 | BCR | 0.50358870 |
| 95 | INSRR | 0.50112439 |
| 96 | FGFR2 | 0.48863072 |
| 97 | BRAF | 0.48726272 |
| 98 | FGR | 0.47540284 |
| 99 | FYN | 0.46865596 |
| 100 | PRKCB | 0.46723149 |
| 101 | * RPS6KA3 | 0.46663397 |
| 102 | BMPR1B | 0.45584737 |
| 103 | CDC42BPA | 0.45552293 |
| 104 | MAPK10 | 0.45423987 |
| 105 | ALK | 0.44326612 |
| 106 | * CSNK1A1 | 0.42872296 |
| 107 | MAP3K7 | 0.41549571 |
| 108 | CCNB1 | 0.40397361 |
| 109 | MAP2K1 | 0.39733549 |
| 110 | LIMK1 | 0.38604283 |
| 111 | PRKCZ | 0.38247943 |
| 112 | CAMK4 | 0.37390541 |
| 113 | MAPK12 | 0.37248661 |
| 114 | CAMK1G | 0.37154049 |
| 115 | TAOK3 | 0.36078631 |
| 116 | DAPK3 | 0.35950594 |
| 117 | MAPK8 | 0.35752854 |
| 118 | FER | 0.35700147 |
| 119 | LATS2 | 0.34814569 |
| 120 | WNK3 | 0.34494479 |
| 121 | DYRK2 | 0.32396195 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.76266142 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.21842833 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.80846629 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.75852195 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.75633314 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.74342485 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.72076755 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.67970885 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.59578922 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.57755410 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.27581948 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.19684305 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.13791339 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.11394140 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.92074974 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.87705730 |
| 17 | Taste transduction_Homo sapiens_hsa04742 | 1.82834163 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.81653816 |
| 19 | Long-term depression_Homo sapiens_hsa04730 | 1.76894962 |
| 20 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.69507270 |
| 21 | Renin secretion_Homo sapiens_hsa04924 | 1.69058835 |
| 22 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.68157978 |
| 23 | Cocaine addiction_Homo sapiens_hsa05030 | 1.65240625 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.62766728 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.61292008 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.60412241 |
| 27 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.42094206 |
| 28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.36879906 |
| 29 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.34050895 |
| 30 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.30684464 |
| 31 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.28875178 |
| 32 | Gap junction_Homo sapiens_hsa04540 | 1.27394890 |
| 33 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.26503059 |
| 34 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.15872509 |
| 35 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.15823573 |
| 36 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.15237030 |
| 37 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.12849282 |
| 38 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.05851583 |
| 39 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.04840931 |
| 40 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.04462089 |
| 41 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.03756579 |
| 42 | Glioma_Homo sapiens_hsa05214 | 1.03348289 |
| 43 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.01349318 |
| 44 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.00026028 |
| 45 | Axon guidance_Homo sapiens_hsa04360 | 0.98043884 |
| 46 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.96565800 |
| 47 | Melanogenesis_Homo sapiens_hsa04916 | 0.94327794 |
| 48 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.94064333 |
| 49 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.93390003 |
| 50 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.88425136 |
| 51 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.82853867 |
| 52 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.81456772 |
| 53 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81219114 |
| 54 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80836743 |
| 55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.80645860 |
| 56 | Phototransduction_Homo sapiens_hsa04744 | 0.80028454 |
| 57 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.76688229 |
| 58 | Histidine metabolism_Homo sapiens_hsa00340 | 0.74862501 |
| 59 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.74810580 |
| 60 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.68844369 |
| 61 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68775747 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68630160 |
| 63 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67906692 |
| 64 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.63687314 |
| 65 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.60540698 |
| 66 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59954672 |
| 67 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.59653071 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56909429 |
| 69 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.56729641 |
| 70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55698513 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55627271 |
| 72 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53898667 |
| 73 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53612412 |
| 74 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51534974 |
| 75 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.51514196 |
| 76 | Alzheimers disease_Homo sapiens_hsa05010 | 0.51100672 |
| 77 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.49248460 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.48108185 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47773402 |
| 80 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44549281 |
| 81 | Bile secretion_Homo sapiens_hsa04976 | 0.44273227 |
| 82 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43930402 |
| 83 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43542755 |
| 84 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.43024983 |
| 85 | Alcoholism_Homo sapiens_hsa05034 | 0.42717886 |
| 86 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41845046 |
| 87 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.41793304 |
| 88 | Circadian rhythm_Homo sapiens_hsa04710 | 0.41105550 |
| 89 | ABC transporters_Homo sapiens_hsa02010 | 0.40961642 |
| 90 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39830881 |
| 91 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38536698 |
| 92 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.38345124 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.37060643 |
| 94 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.36711566 |
| 95 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36272539 |
| 96 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.35776828 |
| 97 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.35328593 |
| 98 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.33540355 |
| 99 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.32387491 |
| 100 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.31275344 |
| 101 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.31070619 |
| 102 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.31029264 |
| 103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30573163 |
| 104 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.30011878 |
| 105 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.29923713 |
| 106 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.29694173 |
| 107 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.29598774 |
| 108 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.29205955 |
| 109 | Parkinsons disease_Homo sapiens_hsa05012 | 0.28791345 |
| 110 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.27076314 |
| 111 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.26391924 |
| 112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.26229842 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | 0.24090297 |
| 114 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.23980278 |
| 115 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.20220202 |
| 116 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.17460668 |
| 117 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.16707986 |

